Please login to the form below

Not currently logged in
Email:
Password:

Aerie Pharmaceuticals appoints new members of its commercialisation team

David Biddell, Shaun Gentry and Erin Horn join the firm

Eye-disease focused pharmaceutical company Aerie Pharmaceuticals has appointed a trio of new comers to its commercialisation team.

David Biddell joins the US group as its regional sales director for the southeast region, reporting to Gary Menichini who is currently vice president of sales.

Meanwhile, Shaun Gentry and Erin Horn both join from Novartis as directors of national accounts in the market access group.

They will both report to Dale Seibt, who is vice president of market access for North Carolina-based Aerie.

28th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics